PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930103
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930103
The global knee replacement market is poised for significant growth over the next decade, driven by rising prevalence of knee osteoarthritis, an expanding geriatric population, and increasing adoption of minimally invasive and robotic-assisted surgical procedures. According to Fortune Business Insights, the market was valued at USD 9.37 billion in 2025, projected to reach USD 9.81 billion in 2026, and is expected to grow to USD 14.65 billion by 2034, representing a CAGR of 5.15% from 2026 to 2034. North America dominated the market in 2025 with a 50.75% share, owing to a large patient pool, advanced healthcare infrastructure, and favorable reimbursement policies.
Market Overview
Knee arthroplasty, commonly known as knee replacement surgery, involves removing damaged cartilage and tissues from the knee joint and replacing them with an artificial implant. The demand for these procedures has increased due to rising cases of osteoarthritis, rheumatoid arthritis, and psoriatic arthritis globally. According to the Arthritis Foundation, approximately 14 million people in the U.S. have symptomatic knee osteoarthritis, with over 600,000 knee replacement surgeries performed annually. Additionally, younger patients with high BMI are contributing to growing surgery volumes.
The COVID-19 pandemic significantly impacted elective procedures such as knee replacement, leading to revenue drops for orthopedic companies due to delayed surgeries, supply chain disruptions, and reduced hospital visits. Non-urgent orthopedic procedures were classified under Tier 2a by the Centers for Medicare and Medicaid Services, resulting in widespread postponements.
Market Drivers
Market Restraints
High costs of orthopedic procedures and limited availability of skilled surgeons restrict market penetration, particularly in developing regions. Knee implants are expensive due to advanced materials and regulatory compliance, limiting access for patients with lower income levels.
Market Segmentation
By Procedure:
By Implant Type:
By End User:
Key Industry Players
Leading companies include Zimmer Biomet, Stryker, DePuy Synthes (Johnson & Johnson), Smith & Nephew, Aesculap (B. Braun), Medacta International, MicroPort Scientific Corporation, and Conformis. These players focus on R&D, innovative implants, and strategic partnerships to expand market presence. Notable developments include FDA clearance for Think Surgical's TSolution One system in 2019 and Zimmer Biomet's launch of the Persona Partial Knee System in 2017.
Conclusion
The global knee replacement market is expected to grow from USD 9.37 billion in 2025 to USD 14.65 billion by 2034, driven by the rising prevalence of osteoarthritis, technological advancements in surgical procedures, and increased adoption of robot-assisted surgeries. North America remains the dominant market, while Asia Pacific offers the fastest growth potential. Total knee arthroplasty and fixed bearing implants lead their respective segments, while hospitals remain the largest end-user base. Strategic innovations and partnerships by key players will continue to shape the competitive landscape and drive long-term market expansion.
Segmentation By Procedure
By Implant Type
By End-user
By Region